Aadi Bioscience (FRA:3350) FCF Yield % : -141.07 (As of Jun. 07, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Aadi Bioscience's Trailing 12-Month Free Cash Flow is €-56.68 Mil, and Market Cap is €39.97 Mil. Therefore, Aadi Bioscience's FCF Yield % for today is -141.07%.

The historical rank and industry rank for Aadi Bioscience's FCF Yield % or its related term are showing as below:

FRA:3350' s FCF Yield % Range Over the Past 10 Years
Min: -144.77 Med: -22.15 Max: 0.71
Current: -141.07

During the past 4 years, the highest FCF Yield % of Aadi Bioscience was 0.71%. The lowest was -144.77%. And the median was -22.15%.

FRA:3350's FCF Yield % is ranked worse than
89.05% of 1553 companies
in the Biotechnology industry
Industry Median: -14.28 vs FRA:3350: -141.07

Aadi Bioscience's FCF Margin % for the quarter that ended in Mar. 2024 was -380.93%.

Aadi Bioscience FCF Yield % Historical Data

The historical data trend for Aadi Bioscience's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience FCF Yield % Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-4.62

-16.70

-127.09

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial										-34.43	-41.70	-43.16	-83.56	-140.20

Competitive Comparison of Aadi Bioscience's FCF Yield %

For the Biotechnology subindustry, Aadi Bioscience's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aadi Bioscience's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's FCF Yield % falls into.

Aadi Bioscience FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Aadi Bioscience's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-58.353	/	45.916354
	=	-127.09%

Aadi Bioscience's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-18.761	*	4	/	53.528156
	=	-140.20%

Aadi Bioscience FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Aadi Bioscience FCF Yield % Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines